lubeluzole has been researched along with Cerebrovascular Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Keyser, J; Diener, HC; Hacke, W; Hantson, L; Hennerici, M; Rådberg, J | 1 |
| Aronowski, J; Grotta, JC; Strong, R | 1 |
| Dyker, AG; Lees, KR | 1 |
| Grotta, J | 1 |
| Lodder, J | 1 |
| Lees, KR | 1 |
1 review(s) available for lubeluzole and Cerebrovascular Disorders
| Article | Year |
|---|---|
The rationale for new therapies in acute ischaemic stroke.
Topics: Cerebrovascular Disorders; Disease Models, Animal; Humans; Neuroprotective Agents; Piperidines; Plasminogen Activators; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Thiazoles; Thrombolytic Therapy; Tissue Plasminogen Activator | 1996 |
2 trial(s) available for lubeluzole and Cerebrovascular Disorders
| Article | Year |
|---|---|
Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases; Cerebrovascular Disorders; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Male; Middle Aged; Multivariate Analysis; Piperidines; Placebos; Safety; Thiazoles | 1996 |
Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Disorders; Double-Blind Method; Female; Heart Diseases; Humans; Male; Middle Aged; Mortality; Neuroprotective Agents; Piperidines; Survival Analysis; Thiazoles; Treatment Outcome | 1997 |
3 other study(ies) available for lubeluzole and Cerebrovascular Disorders
| Article | Year |
|---|---|
Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia.
Topics: Animals; Aspirin; Cardiovascular Agents; Cerebral Infarction; Cerebrovascular Disorders; Drug Therapy, Combination; Hemodilution; Hemoglobins; Male; Neuroprotective Agents; Piperidines; Rats; Rats, Inbred Strains; Reperfusion; Thiazoles | 1996 |
Lubeluzole treatment of acute ischemic stroke.
Topics: Acute Disease; Brain Ischemia; Cardiovascular Agents; Cerebrovascular Disorders; Humans; Piperidines; Thiazoles | 1998 |
Does neuroprotection improve stroke outcome?
Topics: Cerebrovascular Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Neuroprotective Agents; Piperidines; Randomized Controlled Trials as Topic; Research Design; Thiazoles; Thrombolytic Therapy; Time Factors; Treatment Outcome | 1998 |